Now, a study led by the University of Barcelona reveals that the functional assay dynamic BH3 profiling (DBP) can predict whether this treatment will be effective in these cancer patients and thus ...

The discussion that follows describes priming in terms of activator BH3-only proteins, as that is what we have consistently observed. However, adherents to the indirect activation model may ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.